Abstract
Culture procedures are presented that support the initiation and controlled expansion of the multipotent adult progenitor cell (MAPC) population within the human bone marrow derived multipotent mesenchymal stromal cell compartment. Culture procedures or conditions and characterization assays that maintain and survey the distinctive primitive MAPC properties are discussed in the context of cell culturing platforms that facilitate controlled expansion of clinical grade human MAPC product to levels required for mid to late stage clinical testing.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Verfaillie CM, Schwartz R, Reyes M et al (2003) Unexpected potential of adult stem cells. Ann N Y Acad Sci 996:231–234
Jacobs SA, Pinxteren J, Roobrouck VD et al (2013) Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses. Cell Transplant 22:1915–1928
Jacobs SA, Roobrouck VD, Verfaillie CM et al (2013) Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol Cell Biol 91:32–39
Auletta JJ, Cooke KR, Solchaga LA et al (2010) Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant 16:891–906
Vaes B, Van't Hof W, Deans R (2012) Application of MultiStem((R)) allogeneic cells for immunomodulatory therapy: clinical progress and pre-clinical challenges in prophylaxis for graft versus host disease. Front Immunol 3:345
Jiang Y, Vaessen B, Lenvik T et al (2002) Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30:896–904
Subramanian K, Geraerts M, Pauwelyn KW et al (2010) Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow. Methods Mol Biol 636:55–78
Bravery CA, Carmen J, Fong T et al (2013) Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy 15:9–19
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Roobrouck VD, Clavel C, Jacobs SA et al (2011) Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29:871–882
Lehman N, Cutrone R, Raber A et al (2012) Development of a surrogate angiogenic potency assay for clinical-grade stem cell production. Cytotherapy 14:994–1004
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Vaes, B. et al. (2015). Culturing Protocols for Human Multipotent Adult Stem Cells. In: Rich, I. (eds) Stem Cell Protocols. Methods in Molecular Biology, vol 1235. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1785-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1785-3_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1784-6
Online ISBN: 978-1-4939-1785-3
eBook Packages: Springer Protocols